139 related articles for article (PubMed ID: 8117187)
1. 5-Lipoxygenase and 12-lipoxygenase: attractive targets for the development of novel antipsoriatic drugs.
Müller K
Arch Pharm (Weinheim); 1994 Jan; 327(1):3-19. PubMed ID: 8117187
[No Abstract] [Full Text] [Related]
2. Benzophenanthridine alkaloids of Chelidonium majus; I. Inhibition of 5- and 12-lipoxygenase by a non-redox mechanism.
Vavrecková C; Gawlik I; Müller K
Planta Med; 1996 Oct; 62(5):397-401. PubMed ID: 9005450
[TBL] [Abstract][Full Text] [Related]
3. Red-kerneled rice proanthocyanidin inhibits arachidonate 5-lipoxygenase and decreases psoriasis-like skin inflammation.
Toda K; Tsukayama I; Nagasaki Y; Konoike Y; Tamenobu A; Ganeko N; Ito H; Kawakami Y; Takahashi Y; Miki Y; Yamamoto K; Murakami M; Suzuki-Yamamoto T
Arch Biochem Biophys; 2020 Aug; 689():108307. PubMed ID: 32112739
[TBL] [Abstract][Full Text] [Related]
4. Diphyllin acetylapioside, a 5-lipoxygenase inhibitor from Haplophyllum hispanicum.
Prieto JM; Giner RM; Recio Mf MC; Schinella G; Máñez S; Ríos JL
Planta Med; 2002 Apr; 68(4):359-60. PubMed ID: 11988863
[TBL] [Abstract][Full Text] [Related]
5. Lipid metabolism: 5-lipoxygenase, 12/15-lipoxygenase, and atherogenesis.
Davidson J; Rotondo D
Curr Opin Lipidol; 2007 Feb; 18(1):107-9. PubMed ID: 17218838
[No Abstract] [Full Text] [Related]
6. Anthralin derivatives--inhibition of 5-lipoxygenase--antipsoriatic efficacy.
Tanzer H; Braun C; Seidel M; Wiegrebe W
Arch Pharm (Weinheim); 1991 Nov; 324(11):841-6. PubMed ID: 1804060
[TBL] [Abstract][Full Text] [Related]
7. Testing of lipoxygenase inhibitors, cyclooxygenase inhibitors, drugs with immunomodulating properties and some reference antipsoriatic drugs in the modified mouse tail test, an animal model of psoriasis.
Bosman B
Skin Pharmacol; 1994; 7(6):324-34. PubMed ID: 7946375
[TBL] [Abstract][Full Text] [Related]
8. On the interfacial phenomena in lipoxygenase catalysis.
Butovich IA; Kharchenko OV; Babenko VM
Adv Prostaglandin Thromboxane Leukot Res; 1995; 23():159-61. PubMed ID: 7732824
[No Abstract] [Full Text] [Related]
9. The potential of 12/15-lipoxygenase inhibitors in stroke therapy.
van Leyen K; Holman TR; Maloney DJ
Future Med Chem; 2014; 6(17):1853-5. PubMed ID: 25495979
[No Abstract] [Full Text] [Related]
10. Differential effects of malotilate on 5-, 12- and 15-lipoxygenase in human ascites cells.
Vermeer MA; Wilson JH; Zijlstra FJ; Vincent JE
Agents Actions; 1989 Jan; 26(1-2):252-3. PubMed ID: 2496593
[No Abstract] [Full Text] [Related]
11. Recent advances in the search for novel 5-lipoxygenase inhibitors for the treatment of asthma.
Bruno F; Spaziano G; Liparulo A; Roviezzo F; Nabavi SM; Sureda A; Filosa R; D'Agostino B
Eur J Med Chem; 2018 Jun; 153():65-72. PubMed ID: 29133059
[TBL] [Abstract][Full Text] [Related]
12. Expression of lipoxygenase in human prostate cancer and growth reduction by its inhibitors.
Matsuyama M; Yoshimura R; Mitsuhashi M; Hase T; Tsuchida K; Takemoto Y; Kawahito Y; Sano H; Nakatani T
Int J Oncol; 2004 Apr; 24(4):821-7. PubMed ID: 15010818
[TBL] [Abstract][Full Text] [Related]
13. Differential effects of malotilate on 5-, 12- and 15-lipoxygenase in human ascites cells.
Zijlstra FJ; Wilson JH; Vermeer MA; Ouwendijk RJ; Vincent JE
Eur J Pharmacol; 1989 Jan; 159(3):291-5. PubMed ID: 2537738
[TBL] [Abstract][Full Text] [Related]
14. Improved purification of 12-lipoxygenase from rat basophilic leukemia cells and conditions for optimal enzyme activity.
Van der Donk EM; Dubois GR; Verhagen J; Veldink GA; Vliegenthart JF
Biochim Biophys Acta; 1991 Aug; 1074(3):443-7. PubMed ID: 1888756
[TBL] [Abstract][Full Text] [Related]
15. 1'-Hydroxyeugenol- and coniferyl alcohol derivatives as effective inhibitors of 5-lipoxygenase and Cu(2+)-mediated low density lipoprotein oxidation. Evidence for a dual mechanism.
Deigner HP; Wolf G; Ohlenmacher U; Reichling J
Arzneimittelforschung; 1994 Aug; 44(8):956-61. PubMed ID: 7945541
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of leukotriene production by inhibitors of lipoxygenation.
Garland LG; Hodgson ST
Adv Prostaglandin Thromboxane Leukot Res; 1994; 22():33-48. PubMed ID: 7771347
[No Abstract] [Full Text] [Related]
17. Contribution of 5- and 12-lipoxygenase products to mechanical hyperalgesia induced by prostaglandin E(2) and epinephrine in the rat.
Aley O; Levine JD
Exp Brain Res; 2003 Feb; 148(4):482-7. PubMed ID: 12582831
[TBL] [Abstract][Full Text] [Related]
18. Modulators of cutaneous inflammation and proliferation in psoriasis.
Kragballe K; Fisher G; Voorhees JJ
Immunol Ser; 1989; 46():403-24. PubMed ID: 2518721
[No Abstract] [Full Text] [Related]
19. Antipsoriatic drugs as inhibitors of soybean lipoxygenase. A possible mode of action.
Sircar JC; Schwender CF
Prostaglandins Leukot Med; 1983 Aug; 11(4):373-80. PubMed ID: 6413980
[TBL] [Abstract][Full Text] [Related]
20. Chamazulene: an antioxidant-type inhibitor of leukotriene B4 formation.
Safayhi H; Sabieraj J; Sailer ER; Ammon HP
Planta Med; 1994 Oct; 60(5):410-3. PubMed ID: 7997466
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
